Surfactin effectively improves bioavailability of curcumin by formation of nano-capsulation

Colloids Surf B Biointerfaces. 2022 Jul:215:112521. doi: 10.1016/j.colsurfb.2022.112521. Epub 2022 Apr 26.

Abstract

To improve the bioavailability of curcumin, surfactin was used to prepare curcumin-loaded nanoemulsions (Cur-NEs). Moreover, the physicochemical properties, digestive characteristics, as well as inhibition activity to Caco-2 cells of Cur-NEs were measured. Furthermore, the morphological analysis revealed that Cur-NEs with 320 mg/L surfactin appeared spherical nanoparticale (23.23 ± 2.86 nm) and uniform distribution. The encapsulation efficiency of Cur-NEs with 320 mg/L surfactin was 97.25 ± 1.28%. Simulated gastrointestinal digestion results indicated that surfactin elevated the sustained-release characteristics and higher bioaccessibility (40.92 ± 2.84%) of curcumin. Besides, Cur-NEs with 320 mg/L surfactin exhibited excellent stability in different temperature, pH and light irradiation. In addition, the inhibition of Cur-NEs with 320 mg/L surfactin to Caco-2 cells was 71.29%. Biochemical analysis showed that Cur-NEs enhanced the activity of lactate dehydrogenase, superoxide dismutase, catalase and glutathione peroxidase, as well as the reactive oxygen species content. RT-PCR and ELISA results also revealed that Cur-NEs inhibited Caco-2 cells through the activated mitochondria-mediated pathway. This study provided a strategy to encapsulate curcumin in nanoparticles with surfactin for improving bioavailability.

Keywords: Caco-2 cells; Curcumin; Nanoemulsion; Physiochemical property; Surfactin.

MeSH terms

  • Biological Availability
  • Caco-2 Cells
  • Curcumin* / chemistry
  • Digestion
  • Drug Carriers / chemistry
  • Humans
  • Nanoparticles* / chemistry
  • Particle Size

Substances

  • Drug Carriers
  • Curcumin